An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis

Absztrakt
Leírás
Kulcsszavak
Forrás
BMC Nephrology. -23 : 1 (2022), p. 1-15. -BMC Nephrol. - 1471-2369